Dustin S. Sjuts, President at Revance Therapeutics, Inc. (RVNC), sold 5,000 shares at $30.82 ($154K) on 2023-06-09, disclosed to the SEC on 2023-06-13.
Scheduled sale ($154k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RVNC | SELL | 2023-03-09 | $1.4M | — | Filing → |